Zobrazeno 1 - 10
of 1 716
pro vyhledávání: '"Dopamine/*metabolism"'
Autor:
I. Barla, I. V. Dagla, A. Daskalopoulou, M. Panagiotopoulou, M. Kritikaki, P. Dalezis, N. Thomaidis, A. Tsarbopoulos, D. Trafalis, E. Gikas
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Introduction: Colistin (CMS) is used for the curation of infections caused by multidrug-resistant bacteria. CMS is constrained by toxicity, particularly in kidney and neuronal cells. The recommended human doses are 2.5–5 mg/kg/day, and the toxicity
Externí odkaz:
https://doaj.org/article/c39bd5b2392e4945a8221a124b47b216
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhengkang Su, Kaiyu Guan, Yunbin Liu, Hai Zhang, Zhengwei Huang, Miaomiao Zheng, Ya Zhu, He Zhang, Weihong Song, Xi Li
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 249, Iss , Pp 114340- (2023)
The use of clinical psychoactive drugs often poses unpredictable threats to fetal development. Catechol-O-methyltransferase (COMT) is a key enzyme that regulates dopamine metabolism and a promising target for modulation of cognitive functions. Opicap
Externí odkaz:
https://doaj.org/article/8c07331856444e5aa8871703bdcf289e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yongping Chen, Ruwei Ou, Lingyu Zhang, Xiaojing Gu, Xiaoqin Yuan, Qian-qian Wei, Bei Cao, Bi Zhao, Ying Wu, Huifang Shang
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Background: Impaired dopamine metabolism is associated with Parkinson’s disease (PD). Considering the overlap in the clinical and pathological characteristics between PD and multiple system atrophy (MSA), we investigated the effect of five potentia
Externí odkaz:
https://doaj.org/article/960819aba3bc4946b47bddd5ebacab88
Autor:
Shoko Kakinuma, Minako Beppu, Setsu Sawai, Akitoshi Nakayama, Shigeki Hirano, Yoshitaka Yamanaka, Tatsuya Yamamoto, Chigusa Masafumi, Xiamuxiya Aisihaer, Alimasi Aersilan, Yue Gao, Kenichi Sato, Itoga Sakae, Takayuki Ishige, Motoi Nishimura, Kazuyuki Matsushita, Mamoru Satoh, Fumio Nomura, Satoshi Kuwabara, Tomoaki Tanaka
Publikováno v:
eNeurologicalSci, Vol 19, Iss , Pp - (2020)
Background: Dopamine replacement therapy is an established treatment for motor symptoms of Parkinson's disease, but its long-term use is often limited by the eventual development of motor complications, including levodopa-induced dyskinesia. Genetic
Externí odkaz:
https://doaj.org/article/5b288203a0f74a49a59770d6f5b37aa2
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4, Pp 111-114 (2018)
Tardive drug dystonia / dyskinesia is one of the rare, and at the same time, the most severe motor complications associated with the use of pharmacological drugs. Complex assessment of risk factors for the development of tardive drug-induced side eff
Externí odkaz:
https://doaj.org/article/02e10ff93ae64d17a1feacf2c61fa618
Autor:
Nataly Е. Gruntenko, Yury Yu. Ilinsky, Natalya V. Adonyeva, Elena V. Burdina, Roman A. Bykov, Petr N. Menshanov, Inga Yu. Rauschenbach
Publikováno v:
BMC Evolutionary Biology, Vol 17, Iss S2, Pp 15-22 (2017)
Abstract Background One of the most widespread prokaryotic symbionts of invertebrates is the intracellular bacteria of Wolbachia genus which can be found in about 50% of insect species. Wolbachia causes both parasitic and mutualistic effects on its h
Externí odkaz:
https://doaj.org/article/ca7ec94bd2ad49c1b893cdbf9721e51d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fedorova, Tatyana Dmitrievna, Knudsen, Karoline, Horsager, Jacob, Hansen, Allan K., Okkels, Niels, Gottrup, Hanne, Vang, Kim, Borghammer, Per
Publikováno v:
Fedorova, T D, Knudsen, K, Horsager, J, Hansen, A K, Okkels, N, Gottrup, H, Vang, K & Borghammer, P 2023, ' Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease ', Journal of Parkinson's Disease, vol. 13, no. 4 . https://doi.org/10.3233/JPD-230001
Fedorova, T D, Knudsen, K, Horsager, J, Hansen, A K, Okkels, N, Gottrup, H, Vang, K & Borghammer, P 2023, ' Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease ', Journal of Parkinson's disease, vol. 13, no. 4, pp. 515-523 . https://doi.org/10.3233/JPD-230001
Fedorova, T D, Knudsen, K, Horsager, J, Hansen, A K, Okkels, N, Gottrup, H, Vang, K & Borghammer, P 2023, ' Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease ', Journal of Parkinson's disease . https://doi.org/10.3233/JPD-230001
Fedorova, T D, Knudsen, K, Horsager, J, Hansen, A K, Okkels, N, Gottrup, H, Vang, K & Borghammer, P 2023, ' Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease ', Journal of Parkinson's disease, vol. 13, no. 4, pp. 515-523 . https://doi.org/10.3233/JPD-230001
Fedorova, T D, Knudsen, K, Horsager, J, Hansen, A K, Okkels, N, Gottrup, H, Vang, K & Borghammer, P 2023, ' Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson's Disease ', Journal of Parkinson's disease . https://doi.org/10.3233/JPD-230001
Background:The α-syn Origin site and Connectome model (SOC) proposes that α-synucleinopathies can be divided into two categories: the asymmetrical brain-first, and more symmetrical body-first Lewy body disease. We have hypothesized that most patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8c1bebdca447186eb6c838bd44a9ff
https://pure.au.dk/portal/da/publications/dopaminergic-dysfunction-is-more-symmetric-in-dementia-with-lewy-bodies-compared-to-parkinsons-disease(4a2db42c-b4f7-477d-9a2b-d42ffedf51f3).html
https://pure.au.dk/portal/da/publications/dopaminergic-dysfunction-is-more-symmetric-in-dementia-with-lewy-bodies-compared-to-parkinsons-disease(4a2db42c-b4f7-477d-9a2b-d42ffedf51f3).html